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Abstract CXCR4 is a coreceptor, along with CD4, for human
immunodeficiency virus type 1 (HIV-1). Trimolecular complexes
between HIV-1 glycoprotein (gp)120, CD4 and CXCR4
constitute a prerequisite for HIV entry. We studied whether
CD4 is associated with CXCR4 on CD4+ CXCR4+ cells. Using
the conformation-dependent anti-CXCR4 mAb 12G5, CD4 was
coimmunoprecipitated with CXCR4 from the membrane of U937
cells which support HIV-1LAI efficient infection, and from that of
peripheral blood lymphocytes (PBL). CD4 association with
CXCR4 increased upon PBL coculture for 5 days with
autologous monocytes, decreased upon treatment of the cells or
the CD4-CXCR4 complex with either N-glycanase or stromal
cell derived factor-1K (SDF-1K) and was abolished by incuba-
tion of the cells with both, N-glycanase and SDF-1K. This
indicates that glycans are partly involved in CD4 association
with CXCR4 and may partly explain the inhibitory effect of
SDF-1K on HIV infection. ß 2002 Federation of European
Biochemical Societies. Published by Elsevier Science B.V. All
rights reserved.
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1. Introduction
CD4 is human immunode¢ciency virus type 1 (HIV-1) pri-
mary receptor [1]. However, HIV-1 tropism has been ac-
counted for by usage of CCR5 or CXCR4 [2^10]. CCR5-using
strains (R5) are present throughout the course of infection;
CXCR4-using viruses (X4) [9] develop late in disease [10].
RANTES (regulated on activation normal T cells expressed
and secreted), macrophage in£ammatory protein (MIP)-1K
and MIP-1L inhibit R5 HIV infection of cells expressing
CCR5 and CD4 [6,11^16], while stromal cell derived factor-
1 (SDF-1), a CXCR4-speci¢c ligand, inhibits X4 strain entry
[17]. We have demonstrated that stromal cell derived factor-
1K (SDF-1K) interacts with glycosaminoglycans (GAGs), and
also with mannan or mannose [18,19] and that HIV envelope
glycoproteins (gp) have carbohydrate binding properties [20^
28]. Therefore, glycans and GAGs could play a role in HIV-1
infection and in the physiology of SDF-1K. Certain subclones
(minus clones) of the U937 cell line do not support infection
and fusion mediated by X4 HIV-1 although the CD4 and
CXCR4 concentrations at their surfaces are similar to those
of clones susceptible to HIV-1 entry (plus clones) [29]. Trimo-
lecular complexes between X4 HIV gp120, CD4 and CXCR4
constitute a prerequisite for HIV entry into CD4+ CXCR4+
cells [30]. A low level of spontaneous coassociation of CD4
and CXCR4 occurred in U937 cells; this coassociation was
observed in a lesser extent in the minus clones than in the plus
ones [31]. Moreover, a gp120 induced ine⁄cient coimmuno-
precipitation of CD4 and CXCR4 was observed in the minus
clones but not in the plus ones [31]. The fact that SDF-1K
binding to U937 cells was inhibited not only by anti-CXCR4
antibodies but also by soluble CD4, has suggested an inter-
action between SDF-1K and CD4 [19]. Moreover, CD4 and
CXCR4 are N-linked glycosylated molecules [32,33]. This
study was designed to further examine the association of
CD4 with CXCR4 which occurs at the membrane of U937
cells, susceptible to HIV-1 entry and to determine whether
such association can also be observed at the membrane of
peripheral blood lymphocytes (PBL). The possible role of gly-
cans, SDF-1K or PBL stimulation by coculture with autolo-
gous monocytes [34] on such association was also investigated.
2. Materials and methods
2.1. SDF-1K labeling
Synthetic SDF-1K (a gift from F. Baleux, Institut Pasteur, Paris,
France), recombinant SDF-1K (Pepro Tech EC LTD, London, UK)
or RANTES (synthetic, a gift from C. Vita, CEA, Saclay, France) (all
at 5 Wg) were radiolabeled as previously described [18,19]. Speci¢c
activities were 0.4 MBq/Wg. Similar data were obtained with both
SDF-1K.
2.2. Cells
HIV-1LAI-susceptible monocytic U937 and lymphoid CEM cells [35]
were cultured as previously described [19]. Ficoll-Hypaque-separated
blood mononuclear cells (PBMC) from cytapheresis of healthy
volunteers (Seine-Saint-Denis Blood Bank, France) were cultured
as previously reported [15,16,36]. Non-adherent cells were then
removed by several washes; they represent more than 98% T- or
B-CD3+ or CD19+ lymphocytes (PBL), as assessed by labeling with
FITC-conjugated mAb anti-CD3 and anti-CD19 mAb (Becton
Dickinson Immunocytometry, Mountain View, CA, USA), followed
by £ow cytometry analysis with a FACScan (Becton Dickinson).
These PBL were cultured for 1 (PBL-1d) or 5 days (PBL-5d) in the
presence of adherent autologous monocytes. The cells (5U105 in 100
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Wl PBS, 0.05% BSA, 0.05% sodium azide) (PBS-BSA-A) were incu-
bated for 30 min at 4‡C with 2.5 Wg anti-CCR5 mAb 2D7, anti-
CXCR4 mAb 12G5 (12G5) or their isotype IgG2a (all from Pharmin-
gen, San Diego, CA, USA); 12G5 recognizes a conformational epi-
tope in ECL2 [37] and inhibits HIV-1LAI mediated cell fusion [35].
Cells were then incubated for 30 min at 4‡C in 100 Wl of FITC-labeled
anti-mouse immunoglobulin goat antibodies or FITC-anti-mouse
IgG2a antibodies (1/20; Beckman-Coulter or Pharmingen, Paris,
France). Alternatively, cells were incubated for 30 min at 4‡C in
PBS-BSA-A with 1 Wg FITC-CD4 (clone 13B.8.2) or its isotype (1
Wg; IgG1-FITC) (both from Beckman-Coulter), then ¢xed in 1%
paraformaldehyde (Sigma-Aldrich) in PBS and analyzed by £ow cy-
tometry. In all these experiments, the non-speci¢c binding of the anti-
bodies to Fc receptors was determined by the use of the respective
isotypes.
2.3. Cell membranes
Membranes, obtained as previously described [19] were submitted
to SDS^PAGE (12% polyacrylamide) under non-reducing conditions,
then electroblotted onto Immobilon strips (Millipore, Paris, France)
[18,19]. In some experiments, strips were incubated for 5^18 h at 20‡C
or 37‡C with native or heat-inactivated 1^2U106 cpm 125I-SDF-1K
(8U1039 M) (10 min at 100‡C in the presence of 1% SDS, 5%
L-mercaptoethanol from Sigma-Aldrich) and exposed at 320‡C for
18^72 h. Alternatively, strips were incubated with anti-CD4 Q4120
mAb (Sigma-Aldrich; a mAb that blocks the binding of gp120 to
CD4), 12G5 or anti-CXCR4 polyclonal antibodies G19 (G19) (Pepro-
tech EC LTD, London, UK; a goat antibody raised against a peptide
mimicking [37] the ¢rst extracellular domain of CXCR4) or the
isotypes (all at 0.2 Wg/ml; Pharmingen or Peprotech) and stained
with HRP-labeled horse anti-mouse antibody followed by ECL
photoluminescence detection (Amersham, Great Chalfont, UK).
2.4. Coimmunoprecipitation of CD4 with CXCR4. E¡ect of
N-glycanase or SDF-1K
The cells (2U108) in 200^500 Wl PBS were incubated for 2 h at 4‡C
with or without 12G5, its isotype or with native SDF-1K (all at 2 Wg).
This cell concentration was used in order to enhance the amount of
CXCR4 recovered after immunoprecipitation with 12G5. Cell viabil-
ity was s 99%, as assessed by trypan blue exclusion dye. Moreover,
the analysis by £ow cytometry of these highly concentrated cells after
their labeling by anti-CXCR4 and anti-CD4 mAbs did not di¡er from
that observed in the presence of more diluted cells. In some experi-
ments, the cells were treated for 4 h at 37‡C with 10 mU N-glycanase
(peptide N-glycosidase F from Flavobacterium meningosepticum ; Gly-
ko Nocato, CA, USA). Cells were then incubated either with Abs or
with 10^50 nM FITC-labeled concanavalin A (ConA; Sigma-Al-
drich), then analyzed by £ow cytometry or lysed by incubation for
30 min on ice, in 20 mM Tris/HCl bu¡er, pH 8.2, 150 mM NaCl, 1%
v/v Brij 97, supplemented with protease inhibitors (all from Sigma-
Aldrich). Lysates were cleared by centrifugation and incubated for
18 h at 4‡C with 100 Wl Sepharose-protein G beads (Pharmacia, Paris,
France). Beads were washed in solubilization bu¡er and resuspended
in 250^500 Wl of 2U Laemmli bu¡er, heated for 10 min at 100‡C in
order to release bound components, and analyzed after electroblotting
by incubation with anti-CXCR4, anti-CD4 Abs, anti-CCR1 mAb
(clone: 53504.111; RpD Systems) or the isotypes. Alternatively, ly-
sates were incubated with the beads conjugated as previously de-
scribed [18,19] with 12G5, goat anti-SDF-1 Abs or the isotypes
(RpD Systems). Beads were then washed and incubated in some ex-
periments with N-glycanase (10 mU for 24 h at 37‡C).
3. Results and discussion
3.1. Electroblotted CXCR4 binds to SDF-1K and 12G5
U937 and CEM cells expressed, as expected CD4 and
CXCR4. 50^60% PBL-1d or PBL-5d expressed CD4; all the
lymphocytes expressed CXCR4 (Fig. 1a and data not shown).
We then observed that CXCR4 from electroblotted mem-
branes of U937 and CEM cells bound its natural ligand,
SDF-1K and a conformation-dependent mAb, 12G5: native
125I-SDF-1K, G19 and 12G5 bound to di¡use or double bands
of 48^55 kDa and 98^100 kDa and slightly to bands of higher
molecular weight (about 150 kDa) (Fig. 1b and c). The
isotypes, anti-CCR1 mAb, heat-treated 125I-SDF-1K or
125I-RANTES, the latter used as negative control (as no
RANTES-speci¢c receptor has been previously detected on
these cells [38]), exerted no binding (Fig. 1b and c). Moreover,
double or simple bands of 48^52 kDa and 96^105 kDa, which
bound to native 125I-SDF-1K and G19 but neither to heat-
denaturated 125I-SDF-1K nor to the isotypes, were observed
with electroblotted cell lysates from PBL-5d (Fig. 1d). This
indicates that several CXCR4 isoforms, interacting with SDF-
1K and the conformation-dependent 12G5, are observed on
electroblotted cell membranes or cell lysates from CXCR4+
cell lines or primary cells, and that under these conditions, the
native conformation of CXCR4 is preserved.
3.2. Coassociation of CD4 with CXCR4: role of cell
stimulation and N-glycans
Proteins of 150 kDa and 48 kDa were immunoprecipitated
by 12G5 from the plasma membranes of U937 cells and were
immunoreactive with this mAb, but not with the isotype (Fig.
2a). Moreover, 150 kDa and 55 kDa proteins from the 12G5
interacting material were immunoreactive with anti-CD4 mAb
Q4120 but not with the isotype (Fig. 2a). When the same
procedure was applied to PBL-1d and PBL-5d, a 48 kDa
protein, immunoreactive with G19 and 12G5, but neither
with their isotypes, nor with anti-CCR1 mAb, was detected.
Moreover, proteins of 36 kDa and 42 kDa, immunoreactive
with 12G5 but not with its isotype, were also noticed (Fig.
2b). A 55 kDa protein was characterized as CD4 by its im-
munoreactivity with anti-CD4 mAb Q4120, but not with its
isotype. However, the amount of this protein was substan-
tially decreased in the 12G5 interacting material from PBL-
1d as compared to PBL-5d (Fig. 2b). No CXCR4 or CD4
proteins were detected when PBL or U937 cells were incu-
bated with the isotype instead of 12G5 (data not shown).
These data indicate the occurrence of CD4-CXCR4 complexes
at the plasma membrane of U937 cells and PBL-5d, which
increase during PBL coculture with autologous monocytes.
When lysates from U937 cells were freshly prepared and
then incubated with 12G5-coated beads, we observed that
di¡use 48^58 kDa and 100^150 kDa proteins from the
12G5 interacting material were immunoreactive with this
mAb, but not with its isotype. Moreover, 55 kDa and 100
kDa proteins from this material were immunoreactive with
anti-CD4 mAb Q4120, but not with its isotype (Fig. 3). There-
fore, CD4-CXCR4 complexes are detected in these lysates.
Treatment of U937 cells with N-glycanase did not modify
their labeling with anti-CXCR4 and anti-CD4 Abs and on
contrary decreased their labeling by FITC-labeled ConA,
which indicates the enzyme e⁄ciency (Table 1). However,
when the treated cells were lysed and incubated with 12G5-
coated beads, the di¡use 100^150 kDa proteins described
above, which are immunoreactive with 12G5 and the 100
kDa proteins, immunoreactive with anti-CD4 mAb Q4120,
were no more observed. Therefore, the CD4-CXCR4 complex
characterized by a molecular weight of 100^150 kDa, disap-
peared after N-glycanase treatment of U937 cells, which sug-
gests that N-glycans are involved in its formation. Moreover,
after this enzyme treatment, a shift from the di¡use 48^58
kDa band, immunoreactive with 12G5, toward a sharp 48
kDa band, occurred (Fig. 3). Therefore, the di¡use migration
of the 48^58 kDa proteins, described above, may be related
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with their heterogeneous glycosylation (Fig. 3). Nevertheless,
the fact that the 55 kDa protein, immunoreactive with anti-
CD4 mAb Q4120, was still detected in the 12G5 interacting
material, even after N-glycanase treatment of the U937 cells
(Fig. 3), indicates that some coassociation of CD4 with
CXCR4 still occurs. Similar data were observed when the
U937 cells were ¢rst incubated with 12G5, then lysed before
the incubation of the CD4-CXCR4-12G5-coated beads with
N-glycanase (data not shown). Moreover, in these latter con-
ditions, the amount of the 55 kDa protein, immunoreactive
with anti-CD4 mAb Q4120, and obtained from PBL-5d, was
substantially decreased (Fig. 2b). The fact that no CD4 or
CXCR4 molecules were detected in the electroblotted super-
natants from the N-glycanase-treated cells or beads rules out
that these molecules have been eluted in the medium during
the enzyme treatment (data not shown). Taken together, our
data suggest that N-linked glycans are partly involved in CD4
association with CXCR4.
Fig. 1. CXCR4 expression of U937 cells, CEM cells or PBL-5d.
a: U937 cells or PBL-5d were labeled with anti-CD4 (by direct im-
muno£uorescence assay) anti-CCR5 mAb 2D7 or 12G5 (by indirect
immuno£uorescence assay) (black peaks) or with the isotypes (white
peaks). b: Membranes from U937 (lanes 1, 3, 5) or CEM cells
(lanes 2, 4, 6) were electroblotted and incubated with native (lanes
1, 2) or heat-denaturated 125I-SDF-1K (lanes 3, 4) or native 125I-
RANTES (lanes 5, 6). c: Membranes from U937 (lanes 1, 3, 5, 7,
9) or CEM cells (lanes 2, 4, 6, 8, 10) were electroblotted and incu-
bated with 12G5 (lanes 1, 2), G19 (lanes 5, 6), the isotypes (lanes 3,
4, 7, 8) or anti-CCR1 mAb (lanes 9, 10). d: Lysates from PBL-5d
were electroblotted and incubated with native (lane 1) or heat-dena-
turated 125I-SDF-1K (lane 2), G19 (lane 3) or the isotype (lane 4).
Data are representative of three to ¢ve independent experiments.
Table 1
U937 cell membrane expression of CD4 and CXCR4 before or after
treatment by N-glycanase
Antibodies used Mean £uorescence intensity
(units)
3N-glycanase +N-glycanase
IgG2a+FITC-anti-mouse (FabP)2 7 5.5
12G5+FITC-anti-mouse (FabP)2 75 64.5
FITC-IgG1 3.5 4
FITC-anti-CD4 mAb (clone 13B.8.23) 28 25
FITC-ConA 50 30
‘FITC’ indicates labeling by FITC. The results are representative of
three independent experiments.
Fig. 1 (Continued)
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3.3. E¡ect of SDF-1K on CD4 association with CXCR4
While SDF-1K did not modify CD4 membrane expression
of the U937 cells, it induced a decrease in their labeling with
12G5, which was related to an internalization of the receptor
and to a competition between the chemokine and the mAb
[19,35] (Table 2). When the U937 cells were lysed after their
incubation with SDF-1K and the SDF-1K-bound components
immobilized on anti-SDF-1 Abs-coated beads, proteins of
100, 70, 63, 55 and 48 kDa, immunoreactive with 12G5, which
may represent several di¡erent CXCR4 conformational states,
were observed. No binding of the isotype was detected (Fig.
4). However, a slight binding of 55 kDa protein to anti-CD4
mAb Q4120 was observed (Fig. 4). In some experiments, a
slight binding of 100 kDa proteins to anti-CD4 mAb Q4120
was also observed (data not shown). Nevertheless, after
N-glycanase treatment of the cells, a shift of the 100 and 70
kDa bands, immunoreactive with 12G5, toward 98 and 68
kDa bands and a decrease of the intensity of the 48 kDa
band, immunoreactive with this antibody, were observed
(Fig. 4). These data further indicate enzyme e⁄ciency. More-
over, no CD4 molecules were detected in the SDF-1K-bound
components. Therefore, the CXCR4 molecules which have
been bound to SDF-1K, are poorly associated with CD4
and N-glycanase treatment of the cells further abolishes the
CD4-CXCR4 association.
4. Conclusion
While HIV-1 gp120 induces an association between CD4
and CXCR4, a low level of constitutive colocalization be-
tween CD4 and CXCR4 has been detected by confocal laser
scanning microscopy on CXCR4 transfected cell lines [39].
Our data indicate that a coassociation of CD4 with CXCR4
occurs, in the absence of HIV gp120, in the plasma membrane
of monocytic U937 cells, which support e⁄cient HIV-1
infection [22] and in that of PBL, previously stimulated by
Fig. 3. E¡ect of N-glycanase on the CD4-CXCR4 complex from
U937 cells. U937 cells were incubated for 4 h at 37‡C in medium
supplemented (lanes 2, 4, 6, 8) or not (lanes 1, 3, 5, 7) with N-gly-
canase, and lysed. CXCR4 and CXCR4-associated molecules were
immunoprecipitated on 12G5-coated beads, and electroblotted.
Strips were incubated with 12G5 (lanes 1, 2), anti-CD4 mAb Q4120
(lanes 3, 4), murine IgG2a (lanes 5, 6), or murine IgG1 (lanes 7, 8).
Results are representative of three independent experiments.
Fig. 2. CD4-CXCR4 complex at the membrane of U937 cells and
PBL. U937 cells (a) PBL-5d or PBL-1d (b) were incubated with
12G5 and lysed. Lysates were incubated with Sepharose-protein G
beads. The retained material from the U937 cells was electroblotted
and incubated with (a) 12G5 (lane 1), anti-CD4 mAb Q4120 (lane
2), murine IgG2a (lane 3), murine IgG1 (lane 4). In b, the speci¢-
cally retained material from PBL-5d was electroblotted and incu-
bated with anti-CD4 mAb Q4120 (lane 1), murine IgG1 (lane2),
G19 (lane 3), goat IgG (lane 4), 12G5 (lane 5), murine IgG2a (lane
6), or anti-CCR1 mAb (lane 7). In some experiments, the proteins
bound to the matrix were incubated with N-glycanase before elec-
troblotting and incubation with anti-CD4 mAb Q4120 (lane 8). The
12G5 interacting material from PBL-1d was electroblotted and incu-
bated with 12G5 (lane 9), murine IgG2a (lane 10), anti-CD4 mAb
Q4120 (lane 11), murine IgG1 (lane 12). Data are representative of
three independent experiments.
Fig. 4. E¡ect of SDF-1K on the CD4-CXCR4 complex from U937
cells. SDF-1K (250 nM) was incubated with U937 cells. Cells were
lysed; the SDF-1K-bound components were immunoprecipitated
with anti-SDF-1K antibody-coated beads, and electroblotted. Strips
were incubated with 12G5 (lane 1), anti-CD4 mAb Q4120 (lane 2),
murine IgG2a (lane 3), or IgG1 (lane 4). The same as above, but
SDF-1K was incubated with N-glycanase-treated U937 cells. Strip
was incubated with 12G5 (lane 5) or anti-CD4 mAb Q4120 (lane 6).
Results are representative of three independent experiments.
Table 2
U937 cell membrane expression of CD4 and CXCR4 in the absence
or the presence of SDF-1K
Antibodies used Mean £uorescence intensity
(units)
3SDF-1K +SDF-1K
IgG2a+FITC-anti-mouse (FabP)2 2 5
12G5+FITC-anti-mouse (FabP)2 45 16
FITC-IgG1 3 2
FITC-anti-CD4 mAb (clone 13B.8.23) 51 53
‘FITC’ indicates labeling by FITC. The results are representative of
three independent experiments.
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5 days coculture in the presence of adherent autologous
monocytes. That this coimmunoprecipitation was only very
slightly detected on PBL-1d suggests that it depends on cell
stimulation. This is in agreement with Singer et al. [40] show-
ing that CD4 and CXCR4 are clustered and closely apposed,
but with lack of constitutive colocalization, on microvilli of
human T cells, cultured in the absence of autologous mono-
cytes. This coassociation, which partly depends on N-glycans
and on the cell activation state, does not occur in a signi¢cant
manner when the CXCR4 molecules are bound to SDF-1K.
Such association, which seems to be a prerequisite for HIV
entry into the cells, represents one possible target for anti-HIV
therapy.
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